Latest Breaking News On - Vanguard diagnostics pvt ltd - Page 1 : vimarsana.com

Enzyme Linked Immunosorbent Assay Market To Reflect Tremendous Growth Potential With A CAGR Of 5.1% by 2030 | Shenzhen YHLO Biotech Co., Ltd., R&D Systems, Biomerieux S.A., Bio-Rad Laboratories, Inc |

10,000 Sachets Of DRDO-Developed Anti-COVID Drug 2-DG Are Now Available In The Market

Air India customers' data leaked in major cyber attack : Bulletin: Business Today

Loading the player... Singapore social media outlets issue correction notice on COVID-19 variant following Kejriwal's remarks Facebook and Twitter along with Singapore's largest media house have complied with the government's directive to issue a correction to the users of social media platforms in the city-state after Delhi Chief Minister Arvind Kejriwal tweeted about a new COVID-19 "Singapore variant". Singapore's Ministry of Health on Thursday invoked the Protection from Online Falsehoods and Manipulation Act (Pofma) in response to a statement circulating online claiming that there is a new variant of COVID-19 which originated in the city-state that is more harmful to children. Kejriwal on Tuesday wrote on Twitter claiming that the new strain of the coronavirus found in Singapore could be very dangerous for children and urged the Indian government to cancel all air links with Singapore.

COVID-19 antibody detection kit DIPCOVAN developed by DRDO - New Delhi Times - India's Only International Newspaper

May 22, 2021 Share Defence Institute of Physiology and Allied Sciences (DIPAS), a laboratory of Defence Research and Development Organisation (DRDO), has developed an antibody detection-based kit ‘DIPCOVAN’, the DIPAS-VDx COVID-19 IgG Antibody Microwell ELISA for sero-surveillance. The DIPCOVAN kit can detect both spike as well as nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent. The kit has been developed in association with Vanguard Diagnostics Pvt Ltd, a development and manufacturing diagnostics company based at New Delhi. DIPCOVAN is intended for the qualitative detection of IgG antibodies in human serum or plasma, targeting SARS-CoV-2 related antigens. It offers a significantly faster turn-around-time as it requires just 75 minutes to conduct the test without any cross reactivity with other diseases. The kit has a shelf life of 18 months.

Dispovan owner to urge DRDO for new name of Covid anti-body kit

DCGI approves DRDO-developed anti-Covid oral drug, could reduce supplemental oxygen dependence With the 35 years old Rs 400 crore medical syringes brand Dispovan and the Defence Research Development Organisation's (DRDO) Dipcovan - coronavirus antibody detection kit - sounding similar, Hindustan Syringes & Medical Devices Ltd will request the defence lab to have a different brand name, said a top company official. "We will politely request DRDO to go in for a different name for the coronavirus antibody detection kit as the brand name Dipcovan sounds very similar to that of our 35 years old medical syringe brand Dispovan," Rajiv Nath, Managing Director, Hindustan Syringes, told IANS.

Dispovan owner to urge DRDO for new name of Covid anti-body kit

DRDO's Indigenous COVID-19 Antibody Detection Kit to Hit the Markets Soon

DRDO's Indigenous COVID-19 Antibody Detection Kit to Hit the Markets Soon DIPCOVAN kit will be very useful for understanding COVID‐19 epidemiology and assessing an individual's previous SARS‐CoV‐2 exposure   |  21 May 2021 3:36 PM GMT New Delhi: Defence Institute of Physiology and Allied Sciences (DIPAS), a laboratory of Defence Research and Development Organisation (DRDO), has developed DIPCOVAN kit, an indigenous COVID-19 antibody detection-based kit, to be sold across India from June first week. It is expected to be available at about Rs 75 per test. The kit will be very useful for understanding COVID‐19 epidemiology and assessing an individual's previous SARS‐CoV‐2 exposure. Reports said that it can detect both spike and nucleocapsid (S&N) proteins of SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent.

DRDO develops antibody test kit DIPCOVAN for early detection of COVID-19

DRDO develops antibody test kit DIPCOVAN for early detection of COVID-19 DRDO develops antibody test kit DIPCOVAN for early detection of COVID-19 ANI / Updated: May 21, 2021, 17:05 IST DRDO) has developed an COVID. DIPCOVAN, the DIPAS-VDx COVID 19 IgG Antibody Microwell ELISA for sero-surveillance has been developed by the Defence Institute of Physiology and Allied Sciences (DIPAS) in association with Delhi-based firm Vanguard Diagnostics Pvt Ltd. According to DRDO, the kit can detect spike as well as nucleocapsid (S and N) proteins of SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent. It was developed indigenously by scientists, followed by extensive validation on over 1000 patient samples at various COVID hospitals in Delhi.

DRDO's DIPAS develops COVID-19 antibody detection kit

The DIPCOVAN kit can detect both spikes as well as nucleocapsid (S&N) proteins of the SARS-CoV-2 virus with a high sensitivity of 97 per cent and specificity of 99 per cent

DRDO develops Covid-19 antibody detection kit

The Defence Research and Development Organisation (DRDO) has developed an antibody detection kit known as Dipcovan, which is expected to be available at Rs 75 per test in the market from June first week onwards.The kit has been developed by the ...